BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $54,000 | -90.1% | 51,308 | -84.1% | 0.00% | – |
Q2 2019 | $547,000 | -4.0% | 322,055 | +90.3% | 0.00% | – |
Q1 2019 | $570,000 | +120.9% | 169,201 | +91.1% | 0.00% | – |
Q4 2018 | $258,000 | -52.7% | 88,524 | 0.0% | 0.00% | – |
Q3 2018 | $545,000 | +104.9% | 88,524 | +118.5% | 0.00% | – |
Q1 2018 | $266,000 | -25.1% | 40,515 | -4.1% | 0.00% | – |
Q4 2017 | $355,000 | -27.3% | 42,267 | 0.0% | 0.00% | – |
Q3 2017 | $488,000 | +3.0% | 42,267 | +4.2% | 0.00% | – |
Q2 2017 | $474,000 | – | 40,563 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |